Program underscores Stealth's commitment to patient access and partnership with the Barth syndrome community NEEDHAM, Mass., Oct. 9, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback